Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.95
+0.01 (0.14%)
At close: Nov 6, 2025, 4:00 PM EST
6.94
-0.01 (-0.14%)
Pre-market: Nov 7, 2025, 8:16 AM EST
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $247.09 million as of November 7, 2025. Its market cap has decreased by -59.01% in one year.
Market Cap
247.09M
Enterprise Value
-27.34M
1-Year Change
-59.01%
Ranking
Category
Stock Price
$6.95
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $251.01M to $247.09M, a decrease of -1.56%. That is a compound annual growth rate of -0.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 247.09M | -59.64% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |